Houlihan Lokey Advises DirectMed Imaging

Houlihan Lokey is pleased to announce that DirectMed Imaging (DirectMed), a portfolio company of NMS Capital (NMS), has been acquired by Frazier Healthcare Partners (Frazier). The transaction closed on October 11, 2024.
Headquartered in Poway, California, DirectMed is a leading aftermarket diagnostic imaging parts, systems, and service provider. With more than 100,000 parts in stock, the company repairs, supports, and sells GE, Siemens, Philips, and Canon/Toshiba MRI, CT, and X-ray parts to healthcare networks, imaging centers, and independent service organizations around the world.
Founded in 2010, NMS is an experienced private equity firm managing assets in excess of $1.5 billion. Since its inception, NMS has partnered with management teams in more than 150 investments and follow-on acquisitions across defined investment themes within the business services and healthcare services industries. The firm’s principal strategy is to create long-term value by providing strategic and operational resources to growth-oriented companies led by founders or experienced management teams.
Frazier is a private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised more than $8 billion of capital for private funds and co-investment opportunities and has invested in more than 200 companies over 33 years. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies.
This transaction further strengthens and highlights Houlihan Lokey’s continued leadership in the medical technology industry. Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the world. In 2023, the group closed 26 transactions and was ranked by LSEG (formerly Refinitiv) as the No. 1 advisor for U.S. M&A transactions under $1 billion.
Houlihan Lokey served as the exclusive financial advisor to DirectMed and NMS, and assisted in initiating, structuring, and negotiating the transaction on their behalf.